Drug intelligence / Profile preview

uracil

Development stage
Phase 3
Lead developer
GSK
Modality
Small Molecules
Administration
Oral
01

Overview

Uracil is a naturally occurring pyrimidine nucleobase found in RNA, where it pairs with adenine. As a drug, uracil is primarily used as an antineoplastic agent in combination with tegafur (as the oral chemotherapy formulation tegafur/uracil or UFT) for the treatment of various cancers, including breast, prostate, liver, and bowel cancer. In this context, uracil acts as a competitive inhibitor of dihydropyrimidine dehydrogenase (DPD), the enzyme responsible for metabolizing 5-fluorouracil (5-FU). By inhibiting DPD, uracil increases the bioavailability and efficacy of 5-FU derived from its prodrug tegafur. This mechanism allows for more effective oral administration of 5-FU-based chemotherapy while reducing gastrointestinal toxicity compared to direct 5-FU administration[1][4][5].

Brand names
Xyfid
Other names
uracil
02

Targets

DPYD (Dihydropyrimidine dehydrogenase)

Beyond the preview

Go deeper on uracil.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on uracil.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call